Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inflammatory bowel diseases and management considerations: fertility and pregnancy.

Literature DB >> 19765367

Inflammatory bowel diseases and management considerations: fertility and pregnancy.

Abstract

Young women with inflammatory bowel disease (IBD) pose a unique set of challenges. These women and their treating physicians must make difficult choices in matters regarding conception, pregnancy, and breastfeeding. This review highlights recent evidence and management issues that arise when taking care of women with IBD in terms of fertility, outcomes, and medication safety in pregnancy and breastfeeding. Ultimately, treatment must be individualized for each patient based on the available evidence and the woman's preferences.

Entities: Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19765367 DOI： 10.1007/s11894-009-0059-6

Source DB: PubMed Journal: Curr Gastroenterol Rep ISSN： 1522-8037

55 in total

1. Teratogen update: azathioprine and 6-mercaptopurine.

Authors: Janine E Polifka; J M Friedman
Journal: Teratology Date: 2002-05

2. Fertility and pregnancy in inflammatory bowel disease.

Authors: M Hudson; G Flett; T S Sinclair; P W Brunt; A Templeton; N A Mowat
Journal: Int J Gynaecol Obstet Date: 1997-08 Impact factor: 3.561

3. Effects of mesalazine substitution on salicylazosulfapyridine-induced seminal abnormalities in men with ulcerative colitis.

Authors: N Kjaergaard; L A Christensen; J G Lauritsen; S N Rasmussen; S H Hansen
Journal: Scand J Gastroenterol Date: 1989-09 Impact factor: 2.423

Inflammatory bowel diseases and management considerations: fertility and pregnancy.

1. Teratogen update: azathioprine and 6-mercaptopurine.

2. Fertility and pregnancy in inflammatory bowel disease.

3. Effects of mesalazine substitution on salicylazosulfapyridine-induced seminal abnormalities in men with ulcerative colitis.

4. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.

5. Possible embryotoxicity of sulfasalazine.

6. Possible teratogenicity of sulfasalazine.

7. Azathioprine treatment during lactation.

8. Female fecundity before and after operation for familial adenomatous polyposis.

9. Possible teratogenicity of sulphasalazine.

10. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.

1. Inflammatory bowel disease in pregnancy.

Review 2. Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

3. Pregnancy and Inflammatory Bowel Disease.

4. Current opinion on treatment of inflammatory bowel disease in pregnant women.